InMed Stock Market Value

INM
 Stock
  

USD 2.74  0.05  1.86%   

InMed Pharmaceuticals' market value is the price at which a share of InMed Pharmaceuticals stock trades on a public exchange. It measures the collective expectations of InMed Pharmaceuticals investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of InMed Pharmaceuticals and determine expected loss or profit from investing in InMed Pharmaceuticals over a given investment horizon. Please see InMed Pharmaceuticals Correlation, InMed Pharmaceuticals Volatility and InMed Pharmaceuticals Alpha and Beta module to complement your research on InMed Pharmaceuticals.
Symbol


Is InMed Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMed Pharmaceuticals. If investors know InMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
M
Return On Assets
(0.56) 
Return On Equity
(1.46) 
The market value of InMed Pharmaceuticals is measured differently than its book value, which is the value of InMed that is recorded on the company's balance sheet. Investors also form their own opinion of InMed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is InMed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMed Pharmaceuticals' market value can be influenced by many factors that don't directly affect InMed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InMed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine InMed Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

InMed Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to InMed Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of InMed Pharmaceuticals.
0.00
11/03/2022
No Change 0.00  0.0 
In 30 days
12/03/2022
0.00
If you would invest  0.00  in InMed Pharmaceuticals on November 3, 2022 and sell it all today you would earn a total of 0.00 from holding InMed Pharmaceuticals or generate 0.0% return on investment in InMed Pharmaceuticals over 30 days. InMed Pharmaceuticals is related to or competes with Addex Therapeutics, Apexigen, Avalo Therapeutics, Black Diamond, Bionomics, Baudax BioInc, and Ginkgo Bioworks. InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products More

InMed Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure InMed Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess InMed Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

InMed Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for InMed Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as InMed Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use InMed Pharmaceuticals historical prices to predict the future InMed Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of InMed Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of InMed Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.142.7017.19
Details
Intrinsic
Valuation
LowReal ValueHigh
0.193.7218.21
Details
2 Analysts
Consensus
LowTarget PriceHigh
6.006.757.50
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-1-0.93-0.87
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as InMed Pharmaceuticals. Your research has to be compared to or analyzed against InMed Pharmaceuticals' peers to derive any actionable benefits. When done correctly, InMed Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in InMed Pharmaceuticals.

InMed Pharmaceuticals Backtested Returns

InMed Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0607, which attests that the entity had -0.0607% of return per unit of volatility over the last 3 months. Macroaxis approach into determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. InMed Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out InMed Pharmaceuticals market risk adjusted performance of (0.09), and Risk Adjusted Performance of (0.010947) to validate the risk estimate we provide.
The company retains a Market Volatility (i.e., Beta) of 2.1325, which attests to a somewhat significant risk relative to the market. Let's try to break down what InMed's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, InMed Pharmaceuticals will likely underperform. Even though it is essential to pay attention to InMed Pharmaceuticals current price history, it is always good to be careful when utilizing equity current price movements. Our approach into determining any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. InMed Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate its performance. InMed Pharmaceuticals has an expected return of -0.88%. Please be advised to check out InMed Pharmaceuticals coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if InMed Pharmaceuticals performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.20  

Weak predictability

InMed Pharmaceuticals has weak predictability. Overlapping area represents the amount of predictability between InMed Pharmaceuticals time series from 3rd of November 2022 to 18th of November 2022 and 18th of November 2022 to 3rd of December 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of InMed Pharmaceuticals price movement. The serial correlation of 0.2 indicates that over 20.0% of current InMed Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.2
Spearman Rank Test0.11
Residual Average0.0
Price Variance0.01

InMed Pharmaceuticals lagged returns against current returns

Autocorrelation, which is InMed Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting InMed Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of InMed Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that InMed Pharmaceuticals stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   
Share
       Timeline  

InMed Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If InMed Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if InMed Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in InMed Pharmaceuticals stock over time.
   Current vs Lagged Prices   
Share
       Timeline  

InMed Pharmaceuticals Lagged Returns

When evaluating InMed Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of InMed Pharmaceuticals stock have on its future price. InMed Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, InMed Pharmaceuticals autocorrelation shows the relationship between InMed Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in InMed Pharmaceuticals.
   Regressed Prices   
Share
       Timeline  

InMed Pharmaceuticals Investors Sentiment

The influence of InMed Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in InMed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to InMed Pharmaceuticals' public news can be used to forecast risks associated with investment in InMed. The trend in average sentiment can be used to explain how an investor holding InMed can time the market purely based on public headlines and social activities around InMed Pharmaceuticals. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
InMed Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for InMed Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average InMed Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on InMed Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InMed Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InMed Pharmaceuticals' short interest history, or implied volatility extrapolated from InMed Pharmaceuticals options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as InMed Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see InMed Pharmaceuticals Correlation, InMed Pharmaceuticals Volatility and InMed Pharmaceuticals Alpha and Beta module to complement your research on InMed Pharmaceuticals. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for analysis

When running InMed Pharmaceuticals price analysis, check to measure InMed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InMed Pharmaceuticals is operating at the current time. Most of InMed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of InMed Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move InMed Pharmaceuticals' price. Additionally, you may evaluate how the addition of InMed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
InMed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of InMed Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of InMed Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...